PGAP3 and gastric cancer: By targeting PGAP3 together with ERBB2, cell proliferation was significantly abrogated in an additive effect, compared to targeting PGAP3 or ERBB2 alone, suggesting that expression of co‐amplified genes is needed to sustain the growth of GC cells.